Does selinesol targeted drug have serious side effects?

Selinexor (Selinexor) is the first oral export protein inhibitor of its kind, approved for use in combination with dexamethasone (Sd) for the treatment of patients with heavily pretreated grade III refractory myeloma (PTS), and in combination with bortezomib and dexamethasone (SVd) for the treatment of patients with 1-3 relapsed/refractory myeloma (RRMM). Selinisol tablets are a targeted drug that exert therapeutic effects by specifically acting on the intracellular nuclear transport protein XPO1. However, the use of any drug may cause some side effects, and selinexol tablets are no exception.

In clinical practice, selinesol use has been associated with gastrointestinal toxicity, anorexia, and fatigue, such as nausea, vomiting, diarrhea, and anorexia, which require active management and may limit its use, especially outside the scope of clinical trials. These common side effects occur early after treatment is initiated and can be managed and alleviated in most patients with reasonable care. For example, doctors often advise patients to pay attention to their diet before and after taking medication and avoid spicy or greasy foods to reduce digestive discomfort.

In addition to the common side effects, selinexol tablets can cause some serious side effects. Although these side effects are rare, they require sufficient attention. Among them, blood-related side effects are one of the more common serious side effects, which may lead to problems such as thrombocytopenia, anemia, leukopenia, and infection. Therefore, when using this drug, doctors will regularly test patients' blood indicators to monitor and manage these side effects in a timely manner. Therefore, it is best to consult and follow the advice of a professional doctor before using this medication.